TrialDiabetes care2013

Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD).

Allison B Goldfine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.